{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:02:19Z","timestamp":1789678939030,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["120686"],"award-info":[{"award-number":["120686"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jpsychires.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T04:27:29Z","timestamp":1328588849000},"page":"540-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population"],"prefix":"10.1016","volume":"46","author":[{"given":"Eva","family":"Choong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bondolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Etter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Jermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Gholam-Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2012.01.014_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","article-title":"Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?","volume":"29","author":"Aichhorn","year":"2006","journal-title":"Drug Safety"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.jcp.0000145347.68664.4e","article-title":"High dose of depot risperidone in a nonresponder schizophrenic patient","volume":"24","author":"Albrecht","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl. 7","key":"10.1016\/j.jpsychires.2012.01.014_bib3","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.bp.107.042853","article-title":"Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials","volume":"193","author":"Alvarez-Jimenez","year":"2008","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib5","series-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","author":"American Diabetes Association, American Psyhiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity","year":"2004"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","article-title":"Mortality of patients with mood disorders: follow-up over 34\u201338 years","volume":"68","author":"Angst","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1999.tb10908.x","article-title":"Body weight gain induced by antipsychotic drugs: mechanisms and management","volume":"100","author":"Baptista","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4088\/JCP.v62n0404","article-title":"Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone","volume":"62","author":"Basson","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00007691-200404000-00014","article-title":"Therapeutic monitoring of psychotropic drugs \u2013 an outline of the AGNP-TDM expert group consensus guideline","volume":"26","author":"Baumann","year":"2004","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4088\/JCP.v68n0614","article-title":"The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study","volume":"68","author":"Birkenaes","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2174\/138945006779025400","article-title":"Susceptibility genes for the side effect of antipsychotics on body weight and obesity","volume":"7","author":"Chagnon","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11606-008-0523-2","article-title":"Expectation to improve cardiovascular risk factors control in participants to a health promotion program","volume":"23","author":"Chiolero","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpba.2009.07.007","article-title":"Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS","volume":"50","author":"Choong","year":"2009","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0920-9964(03)80158-5","article-title":"Risk factors for coronary heart disease in longer term patients on antipsychotic medication: high prevalence of syndrome X","volume":"60","author":"Cohn","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-5618.2008.00625.x","article-title":"Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics","volume":"10","author":"Correll","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/oxfordjournals.schbul.a007074","article-title":"Weight gain with clozapine compared to first generation antipsychotic medications","volume":"30","author":"Covell","year":"2004","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)","volume":"24","author":"De Hert","year":"2009","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00406-010-0142-x","article-title":"Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone","volume":"261","author":"De Hert","year":"2011","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib21","series-title":"Compendium Suisse de M\u00e9dicaments\u00ae","author":"Documed","year":"2010"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10401230802177722","article-title":"Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder","volume":"20","author":"Fiedorowicz","year":"2008","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2261-8-6","article-title":"The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome","volume":"8","author":"Firmann","year":"2008","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib24","series-title":"Chiffres et donn\u00e9es sur les maladies cardio-vasculaires en Suisse","author":"Fondation Suisse de Cardiologie","year":"2002"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jad.2008.09.008","article-title":"Cardiovascular risk in patients with bipolar disorder","volume":"115","author":"Garcia-Portilla","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpsychires.2008.11.001","article-title":"Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course","volume":"43","author":"Gebhardt","year":"2009","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00702-007-0663-2","article-title":"Clozapine\/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders","volume":"114","author":"Gebhardt","year":"2007","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pcd.2008.10.005","article-title":"Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications","volume":"3","author":"Hasnain","year":"2009","journal-title":"Primary Care Diabetes"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007691-200408000-00019","article-title":"Assessment of storage and transport stability of new antidepressant and antipsychotic drugs for a nationwide TDM service","volume":"26","author":"Heller","year":"2004","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0920-9964(01)00256-0","article-title":"Changes in body mass index for individuals with and without schizophrenia, 1987\u20131996","volume":"55","author":"Homel","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4088\/JCP.v62n0204","article-title":"Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia","volume":"62","author":"Kinon","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib33","series-title":"Quetiapine versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2010"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib34","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA: Journal of the American Medical Association"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4088\/JCP.v68n0612","article-title":"Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia","volume":"68","author":"Laursen","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4088\/JCP.v63n0306","article-title":"Correlates of overweight and obesity in 644 patients with bipolar disorder","volume":"63","author":"McElroy","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"Suppl. 3","key":"10.1016\/j.jpsychires.2012.01.014_bib39","first-page":"28","article-title":"Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder","volume":"66","author":"McIntyre","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 23","key":"10.1016\/j.jpsychires.2012.01.014_bib40","first-page":"23","article-title":"Mechanisms of antipsychotic-induced weight gain","volume":"62","author":"McIntyre","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2012.01.014_bib41","first-page":"28","article-title":"Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial","volume":"68","author":"Meyer","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archpsyc.55.7.580","article-title":"The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment","volume":"55","author":"Musselman","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib43","series-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","author":"National Institute of Health","year":"2002"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2012.01.014_bib44","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/070674370605100803","article-title":"The metabolic effects of antipsychotic medications","volume":"51","author":"Newcomer","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib46","series-title":"Statistique de la sant\u00e9","author":"Office f\u00e9d\u00e9ral de la statistique-Neuch\u00e2tel Suisse","year":"2009"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia on Stockholm County, Sweden","volume":"45","author":"Osby","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib48","series-title":"Data analytic methods for generalized linear models","author":"Pregibon","year":"1979"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2307\/2346405","article-title":"Goodness of link tests for generalized linear models","volume":"29","author":"Pregibon","year":"1980","journal-title":"Applied Statistics"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib50","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2010"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00023210-200115070-00004","article-title":"Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications","volume":"15","author":"Russell","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.genhosppsych.2008.04.009","article-title":"Metabolic syndrome in Italian patients with bipolar disorder","volume":"30","author":"Salvi","year":"2008","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1467-789X.2006.00273.x","article-title":"Prevalence of overweight and obesity in the Netherlands","volume":"8","author":"Schokker","year":"2007","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-5618.2008.00599.x","article-title":"Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database","volume":"10","author":"Sicras","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib56","series-title":"Stahl\u2019s essential psychopharmacology \u2013 neuroscientific basis and practical applications","author":"Stahl","year":"2008"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.10.011","article-title":"Results of phase 3 of the CATIE schizophrenia trial","volume":"107","author":"Stroup","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib58","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-0447.2000.101006416.x","article-title":"Atypical antipsychotics and weight gain \u2013 a systematic review","volume":"101","author":"Taylor","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00702-002-0792-6","article-title":"Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine","volume":"110","author":"Theisen","year":"2003","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib60","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","author":"Tschoner","year":"2007","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2307\/3001938","article-title":"One degree of freedom for non-additivity","volume":"5","author":"Tukey","year":"1949","journal-title":"Biometrics"},{"issue":"Suppl. B","key":"10.1016\/j.jpsychires.2012.01.014_bib62","first-page":"157","article-title":"Clozapine and weight gain","volume":"55","author":"Umbricht","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib63","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/gps.1723","article-title":"Depression and the risk for cardiovascular diseases: systematic review and meta analysis","volume":"22","author":"Van der Kooy","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-5618.2007.00520.x","article-title":"Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder","volume":"10","author":"Van Winkel","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib65","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4088\/JCP.v69n0817","article-title":"Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program","volume":"69","author":"Van Winkel","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjmed.2007.08.043","article-title":"Psychotropic drug considerations in depressed patients with metabolic disturbances","volume":"121","author":"Vieweg","year":"2008","journal-title":"American Journal of Medecine"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00004714-199908000-00006","article-title":"Weight gain: side effect of atypical neuroleptics?","volume":"19","author":"Wetterling","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib70","series-title":"Generalized additive models \u2013 an introduction with R. Broken","first-page":"319","article-title":"GAMMs with R","author":"Wood","year":"2006"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1176\/appi.ajp.2008.08081218","article-title":"Metabolic changes associated with second-generation antipsychotic use in Alzheimer\u2019s disease patients: the CATIE-AD study","volume":"166","author":"Zheng","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.014_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann","year":"2003","journal-title":"Journal of Psychiatric Research"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:07:25Z","timestamp":1758366445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0022395612000155"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.01.014","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}